ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

STX Shield Therapeutics Plc

2.90
0.00 (0.00%)
27 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.90 2.80 2.90 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 13.09M -33.29M -0.0429 -0.66 22.49M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 2.90p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 7.65p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £22.49 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.66.

Shield Therapeutics Share Discussion Threads

Showing 21401 to 21423 of 21525 messages
Chat Pages: 861  860  859  858  857  856  855  854  853  852  851  850  Older
DateSubjectAuthorDiscuss
21/11/2024
08:12
They have a great product. So over time success should follow.
bunlop
21/11/2024
08:08
Great update
imjustdandy
21/11/2024
08:08
Just seen the RNS. Excellent.
purchaseatthetop
21/11/2024
07:54
Desperate rampers will be pumping this On another fluffy quickly hashed rns.

Happy sailing 🤦🏻‍♀️🤷🏿‍♀️

ny boy
21/11/2024
07:45
Agree that today's RNS was positive on all fronts & 'should ' be viewed positively.
Our CEO & FD would have been aware of the 225 but that shouldn't have precluded them fro buying.
Let's see what today brings

base7
21/11/2024
07:38
But then it reversed 8% the following day strange
best1467
21/11/2024
07:28
225 is incredible. Shows the incompetence of Walbrook that they don't realise that should have been the headline and focus of the press release.Hopefully serves as a reminder to all how rife insider trading is on this stock. Someone obviously got wind of this on Tuesday hence their rush to take it up 10% just before the close
reviewwworld
21/11/2024
07:24
Nice. May even recoup some of my losses here..
bagpuss67
21/11/2024
07:20
No bad news is welcome and $225 selling price in October not sure anyone including the board saw that coming.
Let’s hope the volume maintains trajectory

best1467
21/11/2024
07:11
Yip, good update, be nice to get this thread talking about the potential going forward rather than dwelling on previous failings and personal vendettas
eringael
21/11/2024
07:08
I thought news coming hence the rise
Good things are on track

qipincha
21/11/2024
07:07
https://www.londonstockexchange.com/news-article/STX/business-update/16774578Nice update
zeus19
21/11/2024
07:07
A very good RNS.
siggs44
20/11/2024
21:05
Factual evidence from AMARETTO with multiple usernames, now using WASHINGMACHINE? Priceless
antonagis
20/11/2024
20:31
and anton
Don’t for one minute think you are one of the big boys ..
Run along now

washingmachine
20/11/2024
20:29
Anton just remember your own past..
Or i will educate this board
With factual evidence
Now run along chap !

washingmachine
20/11/2024
20:26
Big boys don’t forget Bobarth Or his ex disciple AMARETTO, now WASHINGMACHINE
antonagis
20/11/2024
19:16
Big boys never forget bobath !
1 pence

washingmachine
20/11/2024
18:47
Base. If AOP are going to pay 4p a share I am not sure they would allow Directors to buy at 2.7p now. Actually with that deal potentially coming the Directors would be in a closed period I think. The moment it is RNSd, if it happens as stated, the share price rises by 50%.
purchaseatthetop
20/11/2024
18:41
As our share price drifts back towards its lows after yte brief excitement ,my thoughts turn back,again to the previus Proactive when our CEO hinted,in response to my question about Director share buying,that they were previously prohibited but could now buy shares .......yet none of them havent.
If they believe in the potential of the company he & Santosh are running, they would surely be buying as many shares as they could afford if they consider our share price to materially understate our prospective value.
Those in the know are not buying which emits a very poor signal.

base7
20/11/2024
15:19
Zeus. Pfizer have 11,000 sales reps and spend huge sums on marketing and promotion. The only realistic alternative is licensing. They tried that and it d not happen in the USA.
purchaseatthetop
20/11/2024
14:56
What would you have done differently? I take it youre in the pharma business and have knowledge of how to market a new to market drug??
zeus19
20/11/2024
14:56
Toffeeman. The problem they have had is that they had 30 sales persons till May 23 and then 100 max in 2024. With being maybe 5% under those figures and adding in training time, holidays, sickness etc they might have had effectively 65 FTE sales persons in 2024. That is only just over one per US state. So it takes a long time to get to the point where word of mouth or critical mass is hit.
purchaseatthetop
Chat Pages: 861  860  859  858  857  856  855  854  853  852  851  850  Older